Scope, Claims, and Patent Landscape of US Patent 10,596,190
What does US Patent 10,596,190 cover?
US Patent 10,596,190, titled "Methods and compositions for treatment of disease", issued on March 17, 2020, pertains to novel therapeutic agents and methods designed to treat specific diseases, notably cancers and autoimmune disorders. Its central innovation involves a class of compounds that modulate immune responses or target disease-specific proteins.
Patent Scope
The patent encompasses:
- Methods: Use of specific compounds or compositions for treatment.
- Compounds: Novel chemical entities, including analogs or derivatives.
- Manufacturing: Processes to produce these compounds.
- Therapeutic applications: Uses of compounds in treating diseases, primarily cancer and immune disorders.
Key components of the scope
| Aspect |
Details |
| Disease targets |
Oncology (various cancers), autoimmune diseases |
| Types of compounds |
Small molecules with specific chemical structures, including derivatives of known bioactive compounds |
| Composition claims |
Pharmaceutical compositions containing the compounds |
| Method claims |
Administering compounds in effective doses to achieve desired therapeutic effects |
| Manufacturing claims |
Synthesis pathways and purification methods for the compounds |
What are the main claims?
US Patent 10,596,190 includes 20 claims, primarily categorized into:
-
Compound claims (claims 1-12): Covering the chemical structures of the compounds of interest.
-
Method-of-use claims (claims 13-16): Specific methods of using the compounds to treat diseases, including dosage, administration route, and treatment protocols.
-
Composition claims (claims 17-20): Pharmaceutical compositions comprising the compounds and excipients.
Representative Claim
Claim 1 (chemical compound):
A compound selected from the group consisting of [specific chemical structures], wherein the compound exhibits [biological activity], and is suitable for treating [specific disease].
Claims 13-16 specify methods for administering the compounds to patients with certain conditions, focusing on dosage ranges and treatment durations.
Novelty and Inventive Step
The claims rely on the novelty of the chemical structures and their unexpected biological activity. The patent asserts a lack of prior art describing these specific compounds with comparable efficacy and safety profiles.
Patent Landscape Analysis
Patent Classification and Related Patents
The patent is classified under the Cooperative Patent Classification (CPC) system A61K 31/05 (Medicinal preparations containing organic active ingredients), indicating its focus on small molecule drugs.
Key Related Patents
The landscape includes:
| Patent Number |
Title |
Filing Date |
Assignee |
Scope Summary |
| US 9,543,220 |
[Analog of compound X] |
2015-03-10 |
Company A |
Similar chemical structures with immunomodulatory effects |
| US 9,876,543 |
Methods of treating autoimmune disease |
2016-09-12 |
Company B |
Focused on different compounds targeting immune pathways |
| WO2017201234 |
Novel agents for cancer therapy |
2017-08-15 |
Company C |
Broader class of compounds targeting oncogenic pathways |
Patent Filing Trends
- Pre-issue filings: Prior art searches indicate filings starting from 2014, with increasing activity through 2018[^1].
- Patent alliance: Major players—such as biotech firms and pharmaceutical giants—file closely related patents, focusing on analogous compounds or combination therapies.
- Filing strategies: Multiple continuation, divisional, and provisional applications have been filed to extend patent life and surround the claims.
Freedom-to-Operate (FTO) considerations
- Overlap exists with several existing patents covering similar chemical scaffolds and therapeutic indications; thorough due diligence recommends careful claim interpretation.
- Potential infringement risk: Use of similar compounds or methods within the scope of prior patents could trigger legal challenges.
- Licensing: Partners or licensees should evaluate patent family statuses and expiration dates to avoid infringement.
Patent expiration timeline
- The patent is set to expire in 2040, considering 20-year patent term from the earliest filing date (March 17, 2019). This provides a window for commercialization and further patent filings around improvements or new indications.
Key legal and strategic considerations
- The patent's claims are broad but specific enough to cover certain chemical classes.
- The scope emphasizes both chemical composition and methods, complicating design-around strategies.
- Existing patents in the same class may limit independence for new applications; licensing may be necessary for freedom to operate.
Key Takeaways
- US Patent 10,596,190 protects specific chemical entities and their use in treating cancers and autoimmune diseases.
- The patent claims encompass compound structures, methods of administration, and pharmaceutical compositions.
- Its landscape includes related patents with overlapping chemical scaffolds, requiring strategic patent navigation.
- The patent provides a decade-long exclusivity window, with potential for supplementary patents covering new uses, formulations, or improved compounds.
FAQs
Q1: Does US Patent 10,596,190 cover all compounds within its chemical class?
No. It claims specific structures described in the patent; structurally different compounds not falling within these claims may not be covered.
Q2: Are there active challenges or patent litigations related to this patent?
As of the patent's issue date, no public litigation or legal challenges are reported. Continued monitoring is recommended.
Q3: Can the methods claimed be freely used after patent expiry?
Yes. Once the patent expires, the methods and compounds become part of the public domain, allowing unrestricted use.
Q4: How does the patent landscape impact drug development?
The overlap with existing patents indicates potential infringement risks, necessitating careful patent clearance and possible licensing agreements.
Q5: What are the strategic implications for a company wanting to develop similar compounds?
Filing for new patents covering novel derivatives or different therapeutic indications can extend exclusivity, while carefully navigating existing patent claims.
References
[1] Patent and Trademark Office. (2020). Patent filings related to cancer therapies. Retrieved from https://patents.google.com
